Clinical Trial Update: Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the efficacy of rapamycin (sirolimus) for Peutz-Jeghers syndrome; the update notes the trial but does not provide results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peutz-jeghers Syndrome

Drugs mentioned

• Rapamycin (Sirolimus) (sirolimus)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Peutz-Jeghers Syndrome | Phase 4 | Status: UNKNOWN